nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—CYP2D6—Temsirolimus—kidney cancer	0.0745	0.11	CbGbCtD
Proguanil—CYP3A4—Everolimus—kidney cancer	0.0701	0.104	CbGbCtD
Proguanil—CYP1A2—Pazopanib—kidney cancer	0.0475	0.0702	CbGbCtD
Proguanil—CYP3A4—Temsirolimus—kidney cancer	0.0473	0.0701	CbGbCtD
Proguanil—CYP2C9—Capecitabine—kidney cancer	0.0446	0.066	CbGbCtD
Proguanil—CYP2D6—Pazopanib—kidney cancer	0.0391	0.0579	CbGbCtD
Proguanil—CYP1A2—Erlotinib—kidney cancer	0.0339	0.0501	CbGbCtD
Proguanil—CYP2C19—Sorafenib—kidney cancer	0.0298	0.0442	CbGbCtD
Proguanil—CYP2C9—Paclitaxel—kidney cancer	0.0279	0.0413	CbGbCtD
Proguanil—CYP2D6—Erlotinib—kidney cancer	0.0279	0.0413	CbGbCtD
Proguanil—CYP1A2—Sorafenib—kidney cancer	0.0275	0.0408	CbGbCtD
Proguanil—CYP3A4—Pazopanib—kidney cancer	0.0249	0.0368	CbGbCtD
Proguanil—CYP2C9—Sorafenib—kidney cancer	0.0248	0.0367	CbGbCtD
Proguanil—CYP2D6—Sorafenib—kidney cancer	0.0227	0.0336	CbGbCtD
Proguanil—CYP2D6—Vinblastine—kidney cancer	0.0224	0.0332	CbGbCtD
Proguanil—CYP3A4—Erlotinib—kidney cancer	0.0177	0.0263	CbGbCtD
Proguanil—CYP3A4—Paclitaxel—kidney cancer	0.0162	0.024	CbGbCtD
Proguanil—CYP3A4—Sorafenib—kidney cancer	0.0144	0.0214	CbGbCtD
Proguanil—CYP3A4—Vinblastine—kidney cancer	0.0142	0.0211	CbGbCtD
Proguanil—CYP3A4—Vincristine—kidney cancer	0.014	0.0207	CbGbCtD
Proguanil—CYP2D6—Doxorubicin—kidney cancer	0.0138	0.0204	CbGbCtD
Proguanil—CYP3A4—Sunitinib—kidney cancer	0.0117	0.0173	CbGbCtD
Proguanil—CYP3A4—Doxorubicin—kidney cancer	0.00876	0.013	CbGbCtD
Proguanil—CYP2C19—urine—kidney cancer	0.00638	0.118	CbGeAlD
Proguanil—CYP1A2—urine—kidney cancer	0.00521	0.0963	CbGeAlD
Proguanil—CYP2C9—urine—kidney cancer	0.00495	0.0914	CbGeAlD
Proguanil—CYP2E1—urine—kidney cancer	0.00469	0.0866	CbGeAlD
Proguanil—CYP3A4—urine—kidney cancer	0.00377	0.0697	CbGeAlD
Proguanil—CYP2D6—urine—kidney cancer	0.00371	0.0686	CbGeAlD
Proguanil—DHFR—nephron tubule—kidney cancer	0.00302	0.0558	CbGeAlD
Proguanil—DHFR—renal system—kidney cancer	0.00275	0.0507	CbGeAlD
Proguanil—DHFR—kidney—kidney cancer	0.00265	0.049	CbGeAlD
Proguanil—DHFR—cortex of kidney—kidney cancer	0.00258	0.0478	CbGeAlD
Proguanil—DHFR—gonad—kidney cancer	0.00246	0.0455	CbGeAlD
Proguanil—DHFR—cardiac atrium—kidney cancer	0.00246	0.0454	CbGeAlD
Proguanil—CYP1A2—renal system—kidney cancer	0.00128	0.0236	CbGeAlD
Proguanil—CYP2E1—nephron tubule—kidney cancer	0.00126	0.0233	CbGeAlD
Proguanil—Hepatobiliary disease—Erlotinib—kidney cancer	0.00121	0.00603	CcSEcCtD
Proguanil—Hallucination—Everolimus—kidney cancer	0.00118	0.0059	CcSEcCtD
Proguanil—Pancytopenia—Sunitinib—kidney cancer	0.00118	0.00588	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Temsirolimus—kidney cancer	0.00118	0.00587	CcSEcCtD
Proguanil—CYP2E1—renal system—kidney cancer	0.00115	0.0212	CbGeAlD
Proguanil—Cough—Pazopanib—kidney cancer	0.00114	0.00571	CcSEcCtD
Proguanil—Stomatitis—Sorafenib—kidney cancer	0.00112	0.00559	CcSEcCtD
Proguanil—Pancytopenia—Dactinomycin—kidney cancer	0.00112	0.00556	CcSEcCtD
Proguanil—Nervous system disorder—Temsirolimus—kidney cancer	0.00111	0.00556	CcSEcCtD
Proguanil—CYP2E1—kidney—kidney cancer	0.00111	0.0205	CbGeAlD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Pazopanib—kidney cancer	0.00111	0.00553	CcSEcCtD
Proguanil—Skin disorder—Temsirolimus—kidney cancer	0.0011	0.0055	CcSEcCtD
Proguanil—Hepatobiliary disease—Sorafenib—kidney cancer	0.00109	0.00542	CcSEcCtD
Proguanil—Anorexia—Temsirolimus—kidney cancer	0.00108	0.0054	CcSEcCtD
Proguanil—CYP2E1—cortex of kidney—kidney cancer	0.00108	0.02	CbGeAlD
Proguanil—Stomatitis—Sunitinib—kidney cancer	0.00108	0.00538	CcSEcCtD
Proguanil—Immune system disorder—Everolimus—kidney cancer	0.00107	0.00536	CcSEcCtD
Proguanil—Mediastinal disorder—Everolimus—kidney cancer	0.00107	0.00535	CcSEcCtD
Proguanil—Nervous system disorder—Pazopanib—kidney cancer	0.00105	0.00523	CcSEcCtD
Proguanil—Hepatobiliary disease—Sunitinib—kidney cancer	0.00105	0.00522	CcSEcCtD
Proguanil—Mental disorder—Everolimus—kidney cancer	0.00104	0.0052	CcSEcCtD
Proguanil—Skin disorder—Pazopanib—kidney cancer	0.00104	0.00518	CcSEcCtD
Proguanil—Erythema—Everolimus—kidney cancer	0.00103	0.00516	CcSEcCtD
Proguanil—Malnutrition—Everolimus—kidney cancer	0.00103	0.00516	CcSEcCtD
Proguanil—Mediastinal disorder—Erlotinib—kidney cancer	0.00103	0.00516	CcSEcCtD
Proguanil—Stomatitis—Dactinomycin—kidney cancer	0.00102	0.00509	CcSEcCtD
Proguanil—Anorexia—Pazopanib—kidney cancer	0.00102	0.00509	CcSEcCtD
Proguanil—Mental disorder—Erlotinib—kidney cancer	0.001	0.00501	CcSEcCtD
Proguanil—Erythema—Erlotinib—kidney cancer	0.000998	0.00498	CcSEcCtD
Proguanil—Malnutrition—Erlotinib—kidney cancer	0.000998	0.00498	CcSEcCtD
Proguanil—Pancytopenia—Vincristine—kidney cancer	0.000996	0.00497	CcSEcCtD
Proguanil—Decreased appetite—Temsirolimus—kidney cancer	0.000987	0.00492	CcSEcCtD
Proguanil—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00098	0.00489	CcSEcCtD
Proguanil—Pancytopenia—Gemcitabine—kidney cancer	0.000945	0.00472	CcSEcCtD
Proguanil—Immune system disorder—Sorafenib—kidney cancer	0.000932	0.00465	CcSEcCtD
Proguanil—Mediastinal disorder—Sorafenib—kidney cancer	0.00093	0.00464	CcSEcCtD
Proguanil—Decreased appetite—Pazopanib—kidney cancer	0.00093	0.00464	CcSEcCtD
Proguanil—Gastrointestinal pain—Temsirolimus—kidney cancer	0.000928	0.00463	CcSEcCtD
Proguanil—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000923	0.00461	CcSEcCtD
Proguanil—CYP3A4—renal system—kidney cancer	0.000923	0.0171	CbGeAlD
Proguanil—Stomatitis—Vincristine—kidney cancer	0.000912	0.00455	CcSEcCtD
Proguanil—CYP2D6—renal system—kidney cancer	0.000908	0.0168	CbGeAlD
Proguanil—Mental disorder—Sorafenib—kidney cancer	0.000904	0.00451	CcSEcCtD
Proguanil—Cough—Everolimus—kidney cancer	0.000903	0.00451	CcSEcCtD
Proguanil—Malnutrition—Sorafenib—kidney cancer	0.000898	0.00448	CcSEcCtD
Proguanil—Erythema—Sorafenib—kidney cancer	0.000898	0.00448	CcSEcCtD
Proguanil—Abdominal pain—Temsirolimus—kidney cancer	0.000897	0.00448	CcSEcCtD
Proguanil—Body temperature increased—Temsirolimus—kidney cancer	0.000897	0.00448	CcSEcCtD
Proguanil—Immune system disorder—Sunitinib—kidney cancer	0.000897	0.00447	CcSEcCtD
Proguanil—Mediastinal disorder—Sunitinib—kidney cancer	0.000895	0.00446	CcSEcCtD
Proguanil—CYP3A4—kidney—kidney cancer	0.000892	0.0165	CbGeAlD
Proguanil—CYP2D6—kidney—kidney cancer	0.000878	0.0162	CbGeAlD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.000875	0.00437	CcSEcCtD
Proguanil—Gastrointestinal pain—Pazopanib—kidney cancer	0.000874	0.00436	CcSEcCtD
Proguanil—Cough—Erlotinib—kidney cancer	0.000871	0.00435	CcSEcCtD
Proguanil—Mental disorder—Sunitinib—kidney cancer	0.00087	0.00434	CcSEcCtD
Proguanil—Stomatitis—Gemcitabine—kidney cancer	0.000865	0.00432	CcSEcCtD
Proguanil—Malnutrition—Sunitinib—kidney cancer	0.000864	0.00431	CcSEcCtD
Proguanil—Erythema—Sunitinib—kidney cancer	0.000864	0.00431	CcSEcCtD
Proguanil—Abdominal pain—Pazopanib—kidney cancer	0.000845	0.00422	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.000844	0.00421	CcSEcCtD
Proguanil—Hepatobiliary disease—Gemcitabine—kidney cancer	0.000839	0.00419	CcSEcCtD
Proguanil—Hallucination—Vincristine—kidney cancer	0.000835	0.00417	CcSEcCtD
Proguanil—Nervous system disorder—Everolimus—kidney cancer	0.000828	0.00413	CcSEcCtD
Proguanil—Skin disorder—Everolimus—kidney cancer	0.00082	0.00409	CcSEcCtD
Proguanil—Erythema—Dactinomycin—kidney cancer	0.000818	0.00408	CcSEcCtD
Proguanil—Anorexia—Vinblastine—kidney cancer	0.000808	0.00403	CcSEcCtD
Proguanil—Anorexia—Everolimus—kidney cancer	0.000805	0.00402	CcSEcCtD
Proguanil—Nervous system disorder—Erlotinib—kidney cancer	0.000799	0.00399	CcSEcCtD
Proguanil—Skin disorder—Erlotinib—kidney cancer	0.000791	0.00395	CcSEcCtD
Proguanil—Pancytopenia—Paclitaxel—kidney cancer	0.000791	0.00395	CcSEcCtD
Proguanil—Cough—Sorafenib—kidney cancer	0.000784	0.00391	CcSEcCtD
Proguanil—Diarrhoea—Temsirolimus—kidney cancer	0.000777	0.00388	CcSEcCtD
Proguanil—Anorexia—Erlotinib—kidney cancer	0.000777	0.00388	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000759	0.00379	CcSEcCtD
Proguanil—Mediastinal disorder—Vincristine—kidney cancer	0.000757	0.00378	CcSEcCtD
Proguanil—Cough—Sunitinib—kidney cancer	0.000754	0.00376	CcSEcCtD
Proguanil—Decreased appetite—Vinblastine—kidney cancer	0.000737	0.00368	CcSEcCtD
Proguanil—Mental disorder—Vincristine—kidney cancer	0.000736	0.00367	CcSEcCtD
Proguanil—Decreased appetite—Everolimus—kidney cancer	0.000734	0.00366	CcSEcCtD
Proguanil—Diarrhoea—Pazopanib—kidney cancer	0.000732	0.00365	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000731	0.00365	CcSEcCtD
Proguanil—Gastrointestinal disorder—Everolimus—kidney cancer	0.000729	0.00364	CcSEcCtD
Proguanil—Stomatitis—Paclitaxel—kidney cancer	0.000724	0.00361	CcSEcCtD
Proguanil—Vomiting—Temsirolimus—kidney cancer	0.000722	0.0036	CcSEcCtD
Proguanil—Immune system disorder—Gemcitabine—kidney cancer	0.000719	0.00359	CcSEcCtD
Proguanil—Nervous system disorder—Sorafenib—kidney cancer	0.000719	0.00359	CcSEcCtD
Proguanil—Mediastinal disorder—Gemcitabine—kidney cancer	0.000718	0.00358	CcSEcCtD
Proguanil—Rash—Temsirolimus—kidney cancer	0.000716	0.00357	CcSEcCtD
Proguanil—Dermatitis—Temsirolimus—kidney cancer	0.000715	0.00357	CcSEcCtD
Proguanil—Skin disorder—Sorafenib—kidney cancer	0.000712	0.00355	CcSEcCtD
Proguanil—Headache—Temsirolimus—kidney cancer	0.000711	0.00355	CcSEcCtD
Proguanil—Decreased appetite—Erlotinib—kidney cancer	0.000708	0.00353	CcSEcCtD
Proguanil—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000703	0.00351	CcSEcCtD
Proguanil—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000703	0.00351	CcSEcCtD
Proguanil—Anorexia—Sorafenib—kidney cancer	0.000699	0.00349	CcSEcCtD
Proguanil—Erythema—Gemcitabine—kidney cancer	0.000693	0.00346	CcSEcCtD
Proguanil—Gastrointestinal pain—Vinblastine—kidney cancer	0.000693	0.00346	CcSEcCtD
Proguanil—Nervous system disorder—Sunitinib—kidney cancer	0.000692	0.00345	CcSEcCtD
Proguanil—Gastrointestinal pain—Everolimus—kidney cancer	0.00069	0.00345	CcSEcCtD
Proguanil—Skin disorder—Sunitinib—kidney cancer	0.000685	0.00342	CcSEcCtD
Proguanil—Vomiting—Pazopanib—kidney cancer	0.00068	0.00339	CcSEcCtD
Proguanil—Rash—Pazopanib—kidney cancer	0.000674	0.00337	CcSEcCtD
Proguanil—Nausea—Temsirolimus—kidney cancer	0.000674	0.00336	CcSEcCtD
Proguanil—Dermatitis—Pazopanib—kidney cancer	0.000674	0.00336	CcSEcCtD
Proguanil—Anorexia—Sunitinib—kidney cancer	0.000672	0.00336	CcSEcCtD
Proguanil—Abdominal pain—Vinblastine—kidney cancer	0.00067	0.00334	CcSEcCtD
Proguanil—Headache—Pazopanib—kidney cancer	0.00067	0.00334	CcSEcCtD
Proguanil—Abdominal pain—Everolimus—kidney cancer	0.000667	0.00333	CcSEcCtD
Proguanil—Body temperature increased—Everolimus—kidney cancer	0.000667	0.00333	CcSEcCtD
Proguanil—Gastrointestinal pain—Erlotinib—kidney cancer	0.000666	0.00332	CcSEcCtD
Proguanil—Pancytopenia—Capecitabine—kidney cancer	0.000649	0.00324	CcSEcCtD
Proguanil—Abdominal pain—Erlotinib—kidney cancer	0.000644	0.00321	CcSEcCtD
Proguanil—Body temperature increased—Erlotinib—kidney cancer	0.000644	0.00321	CcSEcCtD
Proguanil—Decreased appetite—Sorafenib—kidney cancer	0.000637	0.00318	CcSEcCtD
Proguanil—Anorexia—Dactinomycin—kidney cancer	0.000636	0.00318	CcSEcCtD
Proguanil—Nausea—Pazopanib—kidney cancer	0.000635	0.00317	CcSEcCtD
Proguanil—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000633	0.00316	CcSEcCtD
Proguanil—Decreased appetite—Sunitinib—kidney cancer	0.000613	0.00306	CcSEcCtD
Proguanil—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000609	0.00304	CcSEcCtD
Proguanil—Cough—Gemcitabine—kidney cancer	0.000605	0.00302	CcSEcCtD
Proguanil—Immune system disorder—Paclitaxel—kidney cancer	0.000602	0.00301	CcSEcCtD
Proguanil—Mediastinal disorder—Paclitaxel—kidney cancer	0.000601	0.003	CcSEcCtD
Proguanil—Gastrointestinal pain—Sorafenib—kidney cancer	0.000599	0.00299	CcSEcCtD
Proguanil—Stomatitis—Capecitabine—kidney cancer	0.000594	0.00297	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000586	0.00293	CcSEcCtD
Proguanil—Nervous system disorder—Vincristine—kidney cancer	0.000585	0.00292	CcSEcCtD
Proguanil—Mental disorder—Paclitaxel—kidney cancer	0.000584	0.00292	CcSEcCtD
Proguanil—Erythema—Paclitaxel—kidney cancer	0.000581	0.0029	CcSEcCtD
Proguanil—Malnutrition—Paclitaxel—kidney cancer	0.000581	0.0029	CcSEcCtD
Proguanil—Decreased appetite—Dactinomycin—kidney cancer	0.00058	0.0029	CcSEcCtD
Proguanil—Diarrhoea—Vinblastine—kidney cancer	0.00058	0.00289	CcSEcCtD
Proguanil—Abdominal pain—Sorafenib—kidney cancer	0.000579	0.00289	CcSEcCtD
Proguanil—Body temperature increased—Sorafenib—kidney cancer	0.000579	0.00289	CcSEcCtD
Proguanil—Diarrhoea—Everolimus—kidney cancer	0.000578	0.00288	CcSEcCtD
Proguanil—Gastrointestinal pain—Sunitinib—kidney cancer	0.000577	0.00288	CcSEcCtD
Proguanil—Hepatobiliary disease—Capecitabine—kidney cancer	0.000577	0.00288	CcSEcCtD
Proguanil—Anorexia—Vincristine—kidney cancer	0.000569	0.00284	CcSEcCtD
Proguanil—Abdominal pain—Sunitinib—kidney cancer	0.000558	0.00278	CcSEcCtD
Proguanil—Body temperature increased—Sunitinib—kidney cancer	0.000558	0.00278	CcSEcCtD
Proguanil—Diarrhoea—Erlotinib—kidney cancer	0.000557	0.00278	CcSEcCtD
Proguanil—Nervous system disorder—Gemcitabine—kidney cancer	0.000555	0.00277	CcSEcCtD
Proguanil—Skin disorder—Gemcitabine—kidney cancer	0.00055	0.00274	CcSEcCtD
Proguanil—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000546	0.00272	CcSEcCtD
Proguanil—Anorexia—Gemcitabine—kidney cancer	0.000539	0.00269	CcSEcCtD
Proguanil—Vomiting—Vinblastine—kidney cancer	0.000539	0.00269	CcSEcCtD
Proguanil—Vomiting—Everolimus—kidney cancer	0.000537	0.00268	CcSEcCtD
Proguanil—Rash—Everolimus—kidney cancer	0.000532	0.00266	CcSEcCtD
Proguanil—Dermatitis—Everolimus—kidney cancer	0.000532	0.00265	CcSEcCtD
Proguanil—Headache—Vinblastine—kidney cancer	0.000531	0.00265	CcSEcCtD
Proguanil—Headache—Everolimus—kidney cancer	0.000529	0.00264	CcSEcCtD
Proguanil—Body temperature increased—Dactinomycin—kidney cancer	0.000528	0.00263	CcSEcCtD
Proguanil—Abdominal pain—Dactinomycin—kidney cancer	0.000528	0.00263	CcSEcCtD
Proguanil—Decreased appetite—Vincristine—kidney cancer	0.000519	0.00259	CcSEcCtD
Proguanil—Vomiting—Erlotinib—kidney cancer	0.000518	0.00259	CcSEcCtD
Proguanil—Gastrointestinal disorder—Vincristine—kidney cancer	0.000515	0.00257	CcSEcCtD
Proguanil—Rash—Erlotinib—kidney cancer	0.000514	0.00256	CcSEcCtD
Proguanil—Dermatitis—Erlotinib—kidney cancer	0.000513	0.00256	CcSEcCtD
Proguanil—Headache—Erlotinib—kidney cancer	0.00051	0.00255	CcSEcCtD
Proguanil—Cough—Paclitaxel—kidney cancer	0.000507	0.00253	CcSEcCtD
Proguanil—Nausea—Vinblastine—kidney cancer	0.000503	0.00251	CcSEcCtD
Proguanil—Nausea—Everolimus—kidney cancer	0.000502	0.0025	CcSEcCtD
Proguanil—Diarrhoea—Sorafenib—kidney cancer	0.000501	0.0025	CcSEcCtD
Proguanil—Immune system disorder—Capecitabine—kidney cancer	0.000494	0.00247	CcSEcCtD
Proguanil—Mediastinal disorder—Capecitabine—kidney cancer	0.000493	0.00246	CcSEcCtD
Proguanil—Decreased appetite—Gemcitabine—kidney cancer	0.000492	0.00246	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000491	0.00245	CcSEcCtD
Proguanil—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000489	0.00244	CcSEcCtD
Proguanil—Gastrointestinal pain—Vincristine—kidney cancer	0.000488	0.00243	CcSEcCtD
Proguanil—Nausea—Erlotinib—kidney cancer	0.000484	0.00242	CcSEcCtD
Proguanil—Diarrhoea—Sunitinib—kidney cancer	0.000483	0.00241	CcSEcCtD
Proguanil—Mental disorder—Capecitabine—kidney cancer	0.000479	0.00239	CcSEcCtD
Proguanil—Malnutrition—Capecitabine—kidney cancer	0.000476	0.00238	CcSEcCtD
Proguanil—Erythema—Capecitabine—kidney cancer	0.000476	0.00238	CcSEcCtD
Proguanil—Body temperature increased—Vincristine—kidney cancer	0.000472	0.00235	CcSEcCtD
Proguanil—Abdominal pain—Vincristine—kidney cancer	0.000472	0.00235	CcSEcCtD
Proguanil—Vomiting—Sorafenib—kidney cancer	0.000466	0.00233	CcSEcCtD
Proguanil—Nervous system disorder—Paclitaxel—kidney cancer	0.000465	0.00232	CcSEcCtD
Proguanil—Rash—Sorafenib—kidney cancer	0.000462	0.00231	CcSEcCtD
Proguanil—Dermatitis—Sorafenib—kidney cancer	0.000462	0.0023	CcSEcCtD
Proguanil—Skin disorder—Paclitaxel—kidney cancer	0.00046	0.0023	CcSEcCtD
Proguanil—Headache—Sorafenib—kidney cancer	0.000459	0.00229	CcSEcCtD
Proguanil—Diarrhoea—Dactinomycin—kidney cancer	0.000457	0.00228	CcSEcCtD
Proguanil—Anorexia—Paclitaxel—kidney cancer	0.000452	0.00225	CcSEcCtD
Proguanil—Vomiting—Sunitinib—kidney cancer	0.000448	0.00224	CcSEcCtD
Proguanil—Body temperature increased—Gemcitabine—kidney cancer	0.000447	0.00223	CcSEcCtD
Proguanil—Rash—Sunitinib—kidney cancer	0.000445	0.00222	CcSEcCtD
Proguanil—Dermatitis—Sunitinib—kidney cancer	0.000444	0.00222	CcSEcCtD
Proguanil—Headache—Sunitinib—kidney cancer	0.000442	0.0022	CcSEcCtD
Proguanil—Nausea—Sorafenib—kidney cancer	0.000435	0.00217	CcSEcCtD
Proguanil—Vomiting—Dactinomycin—kidney cancer	0.000425	0.00212	CcSEcCtD
Proguanil—Rash—Dactinomycin—kidney cancer	0.000421	0.0021	CcSEcCtD
Proguanil—Nausea—Sunitinib—kidney cancer	0.000419	0.00209	CcSEcCtD
Proguanil—Pancytopenia—Doxorubicin—kidney cancer	0.000419	0.00209	CcSEcCtD
Proguanil—Cough—Capecitabine—kidney cancer	0.000416	0.00207	CcSEcCtD
Proguanil—Decreased appetite—Paclitaxel—kidney cancer	0.000412	0.00206	CcSEcCtD
Proguanil—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000409	0.00204	CcSEcCtD
Proguanil—Diarrhoea—Vincristine—kidney cancer	0.000408	0.00204	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000403	0.00201	CcSEcCtD
Proguanil—Nausea—Dactinomycin—kidney cancer	0.000397	0.00198	CcSEcCtD
Proguanil—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000387	0.00193	CcSEcCtD
Proguanil—Diarrhoea—Gemcitabine—kidney cancer	0.000387	0.00193	CcSEcCtD
Proguanil—Stomatitis—Doxorubicin—kidney cancer	0.000383	0.00191	CcSEcCtD
Proguanil—Nervous system disorder—Capecitabine—kidney cancer	0.000381	0.0019	CcSEcCtD
Proguanil—Vomiting—Vincristine—kidney cancer	0.000379	0.00189	CcSEcCtD
Proguanil—Skin disorder—Capecitabine—kidney cancer	0.000378	0.00188	CcSEcCtD
Proguanil—Rash—Vincristine—kidney cancer	0.000376	0.00188	CcSEcCtD
Proguanil—Dermatitis—Vincristine—kidney cancer	0.000376	0.00188	CcSEcCtD
Proguanil—Abdominal pain—Paclitaxel—kidney cancer	0.000375	0.00187	CcSEcCtD
Proguanil—Body temperature increased—Paclitaxel—kidney cancer	0.000375	0.00187	CcSEcCtD
Proguanil—Headache—Vincristine—kidney cancer	0.000374	0.00187	CcSEcCtD
Proguanil—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000372	0.00185	CcSEcCtD
Proguanil—Anorexia—Capecitabine—kidney cancer	0.000371	0.00185	CcSEcCtD
Proguanil—Vomiting—Gemcitabine—kidney cancer	0.00036	0.0018	CcSEcCtD
Proguanil—Rash—Gemcitabine—kidney cancer	0.000357	0.00178	CcSEcCtD
Proguanil—Dermatitis—Gemcitabine—kidney cancer	0.000356	0.00178	CcSEcCtD
Proguanil—Headache—Gemcitabine—kidney cancer	0.000355	0.00177	CcSEcCtD
Proguanil—Nausea—Vincristine—kidney cancer	0.000354	0.00177	CcSEcCtD
Proguanil—Decreased appetite—Capecitabine—kidney cancer	0.000338	0.00169	CcSEcCtD
Proguanil—Nausea—Gemcitabine—kidney cancer	0.000336	0.00168	CcSEcCtD
Proguanil—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000336	0.00168	CcSEcCtD
Proguanil—Diarrhoea—Paclitaxel—kidney cancer	0.000324	0.00162	CcSEcCtD
Proguanil—Immune system disorder—Doxorubicin—kidney cancer	0.000319	0.00159	CcSEcCtD
Proguanil—Gastrointestinal pain—Capecitabine—kidney cancer	0.000318	0.00159	CcSEcCtD
Proguanil—Mediastinal disorder—Doxorubicin—kidney cancer	0.000318	0.00159	CcSEcCtD
Proguanil—Mental disorder—Doxorubicin—kidney cancer	0.000309	0.00154	CcSEcCtD
Proguanil—Body temperature increased—Capecitabine—kidney cancer	0.000307	0.00153	CcSEcCtD
Proguanil—Abdominal pain—Capecitabine—kidney cancer	0.000307	0.00153	CcSEcCtD
Proguanil—Erythema—Doxorubicin—kidney cancer	0.000307	0.00153	CcSEcCtD
Proguanil—Malnutrition—Doxorubicin—kidney cancer	0.000307	0.00153	CcSEcCtD
Proguanil—Vomiting—Paclitaxel—kidney cancer	0.000301	0.0015	CcSEcCtD
Proguanil—Rash—Paclitaxel—kidney cancer	0.000299	0.00149	CcSEcCtD
Proguanil—Dermatitis—Paclitaxel—kidney cancer	0.000298	0.00149	CcSEcCtD
Proguanil—Headache—Paclitaxel—kidney cancer	0.000297	0.00148	CcSEcCtD
Proguanil—Nausea—Paclitaxel—kidney cancer	0.000281	0.0014	CcSEcCtD
Proguanil—Cough—Doxorubicin—kidney cancer	0.000268	0.00134	CcSEcCtD
Proguanil—Diarrhoea—Capecitabine—kidney cancer	0.000266	0.00133	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.00026	0.0013	CcSEcCtD
Proguanil—Vomiting—Capecitabine—kidney cancer	0.000247	0.00123	CcSEcCtD
Proguanil—Nervous system disorder—Doxorubicin—kidney cancer	0.000246	0.00123	CcSEcCtD
Proguanil—Rash—Capecitabine—kidney cancer	0.000245	0.00122	CcSEcCtD
Proguanil—Dermatitis—Capecitabine—kidney cancer	0.000245	0.00122	CcSEcCtD
Proguanil—Headache—Capecitabine—kidney cancer	0.000244	0.00122	CcSEcCtD
Proguanil—Skin disorder—Doxorubicin—kidney cancer	0.000243	0.00121	CcSEcCtD
Proguanil—Anorexia—Doxorubicin—kidney cancer	0.000239	0.00119	CcSEcCtD
Proguanil—Nausea—Capecitabine—kidney cancer	0.000231	0.00115	CcSEcCtD
Proguanil—Decreased appetite—Doxorubicin—kidney cancer	0.000218	0.00109	CcSEcCtD
Proguanil—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000216	0.00108	CcSEcCtD
Proguanil—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000205	0.00102	CcSEcCtD
Proguanil—Abdominal pain—Doxorubicin—kidney cancer	0.000198	0.000989	CcSEcCtD
Proguanil—Body temperature increased—Doxorubicin—kidney cancer	0.000198	0.000989	CcSEcCtD
Proguanil—Diarrhoea—Doxorubicin—kidney cancer	0.000171	0.000856	CcSEcCtD
Proguanil—Vomiting—Doxorubicin—kidney cancer	0.000159	0.000795	CcSEcCtD
Proguanil—Rash—Doxorubicin—kidney cancer	0.000158	0.000789	CcSEcCtD
Proguanil—Dermatitis—Doxorubicin—kidney cancer	0.000158	0.000788	CcSEcCtD
Proguanil—Headache—Doxorubicin—kidney cancer	0.000157	0.000784	CcSEcCtD
Proguanil—Nausea—Doxorubicin—kidney cancer	0.000149	0.000743	CcSEcCtD
Proguanil—CYP2E1—Metabolism—CA2—kidney cancer	3.9e-05	0.00056	CbGpPWpGaD
Proguanil—DHFR—Disease—HIF1A—kidney cancer	3.82e-05	0.000548	CbGpPWpGaD
Proguanil—DHFR—Disease—TSC2—kidney cancer	3.81e-05	0.000547	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ALAD—kidney cancer	3.8e-05	0.000546	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GSTM1—kidney cancer	3.8e-05	0.000545	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CCBL1—kidney cancer	3.75e-05	0.000539	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CCBL1—kidney cancer	3.72e-05	0.000534	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MAPK3—kidney cancer	3.71e-05	0.000533	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ST3GAL2—kidney cancer	3.71e-05	0.000533	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.69e-05	0.00053	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.68e-05	0.000529	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.63e-05	0.000521	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ALDH1A1—kidney cancer	3.63e-05	0.000521	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MYC—kidney cancer	3.61e-05	0.000518	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CYP1A1—kidney cancer	3.6e-05	0.000517	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PPAT—kidney cancer	3.54e-05	0.000508	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GLIPR1—kidney cancer	3.54e-05	0.000508	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MAPK1—kidney cancer	3.53e-05	0.000507	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.49e-05	0.000502	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.49e-05	0.000501	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—SLC5A3—kidney cancer	3.48e-05	0.000499	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PGK1—kidney cancer	3.48e-05	0.000499	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.46e-05	0.000497	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.44e-05	0.000494	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—LDHB—kidney cancer	3.41e-05	0.000489	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.39e-05	0.000487	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PDHB—kidney cancer	3.38e-05	0.000486	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—POMC—kidney cancer	3.37e-05	0.000484	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.37e-05	0.000483	CbGpPWpGaD
Proguanil—DHFR—Disease—APC—kidney cancer	3.37e-05	0.000483	CbGpPWpGaD
Proguanil—DHFR—Disease—KIT—kidney cancer	3.37e-05	0.000483	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—FH—kidney cancer	3.29e-05	0.000472	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—APRT—kidney cancer	3.29e-05	0.000472	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PPAT—kidney cancer	3.26e-05	0.000467	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GLIPR1—kidney cancer	3.26e-05	0.000467	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GLIPR1—kidney cancer	3.23e-05	0.000463	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PPAT—kidney cancer	3.23e-05	0.000463	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.22e-05	0.000462	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.19e-05	0.000457	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CCBL1—kidney cancer	3.18e-05	0.000457	CbGpPWpGaD
Proguanil—DHFR—Disease—BRAF—kidney cancer	3.16e-05	0.000454	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.15e-05	0.000453	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GPC3—kidney cancer	3.09e-05	0.000444	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ACY1—kidney cancer	3.07e-05	0.000441	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—FH—kidney cancer	3.03e-05	0.000434	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—APRT—kidney cancer	3.03e-05	0.000434	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CA2—kidney cancer	3.01e-05	0.000432	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—APRT—kidney cancer	3e-05	0.000431	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—FH—kidney cancer	3e-05	0.000431	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TP53—kidney cancer	2.97e-05	0.000426	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CA9—kidney cancer	2.96e-05	0.000424	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ALAD—kidney cancer	2.93e-05	0.000421	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.93e-05	0.000421	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.88e-05	0.000413	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.86e-05	0.000411	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GPC3—kidney cancer	2.85e-05	0.000408	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GPC3—kidney cancer	2.82e-05	0.000405	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.8e-05	0.000402	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CA2—kidney cancer	2.77e-05	0.000397	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.76e-05	0.000396	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PPAT—kidney cancer	2.76e-05	0.000396	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CA2—kidney cancer	2.74e-05	0.000394	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.72e-05	0.000391	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ALAD—kidney cancer	2.7e-05	0.000387	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.7e-05	0.000387	CbGpPWpGaD
Proguanil—DHFR—Metabolism—POMC—kidney cancer	2.68e-05	0.000385	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PGK1—kidney cancer	2.68e-05	0.000385	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.68e-05	0.000385	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ALAD—kidney cancer	2.67e-05	0.000384	CbGpPWpGaD
Proguanil—DHFR—Disease—RAF1—kidney cancer	2.64e-05	0.000379	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.63e-05	0.000378	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—LDHB—kidney cancer	2.63e-05	0.000378	CbGpPWpGaD
Proguanil—DHFR—Disease—ERBB2—kidney cancer	2.61e-05	0.000375	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PDHB—kidney cancer	2.61e-05	0.000375	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.61e-05	0.000375	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—POMC—kidney cancer	2.6e-05	0.000374	CbGpPWpGaD
Proguanil—DHFR—Disease—MTOR—kidney cancer	2.58e-05	0.00037	CbGpPWpGaD
Proguanil—DHFR—Disease—CD4—kidney cancer	2.57e-05	0.00037	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.57e-05	0.000369	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—FH—kidney cancer	2.56e-05	0.000368	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—APRT—kidney cancer	2.56e-05	0.000368	CbGpPWpGaD
Proguanil—DHFR—Disease—PTGS2—kidney cancer	2.56e-05	0.000367	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.55e-05	0.000366	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CRABP1—kidney cancer	2.51e-05	0.000361	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.51e-05	0.00036	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PGK1—kidney cancer	2.47e-05	0.000354	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.47e-05	0.000354	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CCBL1—kidney cancer	2.45e-05	0.000352	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.45e-05	0.000351	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PGK1—kidney cancer	2.45e-05	0.000351	CbGpPWpGaD
Proguanil—DHFR—Disease—CDKN1B—kidney cancer	2.42e-05	0.000347	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—LDHB—kidney cancer	2.42e-05	0.000347	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GPC3—kidney cancer	2.41e-05	0.000346	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—LDHB—kidney cancer	2.4e-05	0.000344	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CA2—kidney cancer	2.34e-05	0.000337	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ITPR2—kidney cancer	2.34e-05	0.000335	CbGpPWpGaD
Proguanil—DHFR—Disease—CTNNB1—kidney cancer	2.29e-05	0.000328	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ALAD—kidney cancer	2.29e-05	0.000328	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CA9—kidney cancer	2.28e-05	0.000327	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ST3GAL2—kidney cancer	2.23e-05	0.00032	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.23e-05	0.00032	CbGpPWpGaD
Proguanil—DHFR—Disease—PTEN—kidney cancer	2.23e-05	0.00032	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.18e-05	0.000313	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PTGS2—kidney cancer	2.14e-05	0.000307	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ACHE—kidney cancer	2.13e-05	0.000306	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTT1—kidney cancer	2.13e-05	0.000306	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PPAT—kidney cancer	2.13e-05	0.000306	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.13e-05	0.000306	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CA9—kidney cancer	2.1e-05	0.000301	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PGK1—kidney cancer	2.09e-05	0.0003	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.09e-05	0.0003	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CA9—kidney cancer	2.08e-05	0.000299	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—LDHB—kidney cancer	2.05e-05	0.000294	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.03e-05	0.000292	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—SCARB1—kidney cancer	2.02e-05	0.00029	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTGS1—kidney cancer	2e-05	0.000287	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—APRT—kidney cancer	1.98e-05	0.000284	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—FH—kidney cancer	1.98e-05	0.000284	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PSMD7—kidney cancer	1.96e-05	0.000281	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CRABP1—kidney cancer	1.94e-05	0.000278	CbGpPWpGaD
Proguanil—DHFR—Disease—MAPK3—kidney cancer	1.9e-05	0.000273	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PTEN—kidney cancer	1.87e-05	0.000268	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GPC3—kidney cancer	1.86e-05	0.000267	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—BCHE—kidney cancer	1.86e-05	0.000267	CbGpPWpGaD
Proguanil—DHFR—Disease—MYC—kidney cancer	1.85e-05	0.000266	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.83e-05	0.000263	CbGpPWpGaD
Proguanil—DHFR—Disease—MAPK1—kidney cancer	1.81e-05	0.00026	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CA2—kidney cancer	1.81e-05	0.00026	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ITPR2—kidney cancer	1.8e-05	0.000259	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CRABP1—kidney cancer	1.78e-05	0.000256	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CA9—kidney cancer	1.78e-05	0.000255	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.77e-05	0.000254	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CRABP1—kidney cancer	1.77e-05	0.000254	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ALAD—kidney cancer	1.76e-05	0.000253	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.74e-05	0.000249	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.72e-05	0.000247	CbGpPWpGaD
Proguanil—DHFR—Disease—KRAS—kidney cancer	1.71e-05	0.000246	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.68e-05	0.000242	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.66e-05	0.000239	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ITPR2—kidney cancer	1.66e-05	0.000238	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ACHE—kidney cancer	1.64e-05	0.000236	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTT1—kidney cancer	1.64e-05	0.000236	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ITPR2—kidney cancer	1.64e-05	0.000236	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PGK1—kidney cancer	1.61e-05	0.000232	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.61e-05	0.000232	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—LDHB—kidney cancer	1.58e-05	0.000227	CbGpPWpGaD
Proguanil—DHFR—Disease—PIK3CA—kidney cancer	1.57e-05	0.000226	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SCARB1—kidney cancer	1.56e-05	0.000223	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTGS1—kidney cancer	1.54e-05	0.000221	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.52e-05	0.000218	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ACHE—kidney cancer	1.51e-05	0.000217	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTT1—kidney cancer	1.51e-05	0.000217	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CRABP1—kidney cancer	1.51e-05	0.000217	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PSMD7—kidney cancer	1.51e-05	0.000217	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTT1—kidney cancer	1.5e-05	0.000215	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ACHE—kidney cancer	1.5e-05	0.000215	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTP1—kidney cancer	1.48e-05	0.000212	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—BCHE—kidney cancer	1.43e-05	0.000206	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SCARB1—kidney cancer	1.43e-05	0.000205	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SCARB1—kidney cancer	1.42e-05	0.000204	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTGS1—kidney cancer	1.42e-05	0.000203	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.41e-05	0.000203	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ITPR2—kidney cancer	1.4e-05	0.000202	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTGS1—kidney cancer	1.4e-05	0.000202	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ABCB1—kidney cancer	1.4e-05	0.000201	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PSMD7—kidney cancer	1.39e-05	0.000199	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PSMD7—kidney cancer	1.38e-05	0.000198	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CA9—kidney cancer	1.37e-05	0.000197	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.37e-05	0.000196	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTM1—kidney cancer	1.36e-05	0.000195	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.33e-05	0.00019	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—BCHE—kidney cancer	1.32e-05	0.000189	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PIK3CA—kidney cancer	1.32e-05	0.000189	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—BCHE—kidney cancer	1.31e-05	0.000187	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.3e-05	0.000187	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.3e-05	0.000186	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.29e-05	0.000185	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.29e-05	0.000185	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTT1—kidney cancer	1.28e-05	0.000184	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ACHE—kidney cancer	1.28e-05	0.000184	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.26e-05	0.00018	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.25e-05	0.000179	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SCARB1—kidney cancer	1.21e-05	0.000174	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.21e-05	0.000174	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTGS1—kidney cancer	1.2e-05	0.000172	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PSMD7—kidney cancer	1.18e-05	0.000169	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CRABP1—kidney cancer	1.17e-05	0.000167	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.16e-05	0.000166	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTP1—kidney cancer	1.14e-05	0.000164	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—BCHE—kidney cancer	1.12e-05	0.00016	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.1e-05	0.000158	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ITPR2—kidney cancer	1.08e-05	0.000156	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ABCB1—kidney cancer	1.08e-05	0.000155	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.06e-05	0.000153	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.05e-05	0.000151	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTP1—kidney cancer	1.05e-05	0.00015	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTM1—kidney cancer	1.05e-05	0.00015	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTP1—kidney cancer	1.04e-05	0.000149	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.03e-05	0.000148	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP1A1—kidney cancer	9.93e-06	0.000143	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ABCB1—kidney cancer	9.92e-06	0.000142	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ACHE—kidney cancer	9.89e-06	0.000142	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTT1—kidney cancer	9.89e-06	0.000142	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ABCB1—kidney cancer	9.84e-06	0.000141	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTM1—kidney cancer	9.63e-06	0.000138	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—POMC—kidney cancer	9.59e-06	0.000138	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTM1—kidney cancer	9.55e-06	0.000137	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SCARB1—kidney cancer	9.36e-06	0.000134	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTGS1—kidney cancer	9.26e-06	0.000133	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP1A1—kidney cancer	9.13e-06	0.000131	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PSMD7—kidney cancer	9.09e-06	0.00013	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP1A1—kidney cancer	9.05e-06	0.00013	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.01e-06	0.000129	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTP1—kidney cancer	8.88e-06	0.000127	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—BCHE—kidney cancer	8.61e-06	0.000124	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.51e-06	0.000122	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ABCB1—kidney cancer	8.41e-06	0.000121	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.22e-06	0.000118	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTM1—kidney cancer	8.16e-06	0.000117	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.16e-06	0.000117	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP1A1—kidney cancer	7.74e-06	0.000111	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTGS2—kidney cancer	7.65e-06	0.00011	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.44e-06	0.000107	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—POMC—kidney cancer	7.4e-06	0.000106	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTP1—kidney cancer	6.85e-06	9.84e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—POMC—kidney cancer	6.81e-06	9.77e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—POMC—kidney cancer	6.75e-06	9.69e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTEN—kidney cancer	6.67e-06	9.58e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCB1—kidney cancer	6.49e-06	9.31e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.36e-06	9.12e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTM1—kidney cancer	6.3e-06	9.04e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.97e-06	8.57e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTGS2—kidney cancer	5.9e-06	8.48e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—POMC—kidney cancer	5.77e-06	8.28e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTGS2—kidney cancer	5.43e-06	7.8e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTGS2—kidney cancer	5.38e-06	7.73e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTEN—kidney cancer	5.15e-06	7.39e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTEN—kidney cancer	4.74e-06	6.8e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CA—kidney cancer	4.71e-06	6.76e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTEN—kidney cancer	4.69e-06	6.74e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTGS2—kidney cancer	4.6e-06	6.6e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—POMC—kidney cancer	4.45e-06	6.39e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTEN—kidney cancer	4.01e-06	5.76e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.63e-06	5.21e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTGS2—kidney cancer	3.55e-06	5.1e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.34e-06	4.8e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.31e-06	4.75e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTEN—kidney cancer	3.1e-06	4.44e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.83e-06	4.06e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.18e-06	3.14e-05	CbGpPWpGaD
